Quidel Co. (NASDAQ:QDEL) SVP Ratan S. Borkar sold 29,880 shares of the company’s stock in a transaction dated Thursday, January 4th. The stock was sold at an average price of $45.15, for a total transaction of $1,349,082.00. Following the transaction, the senior vice president now owns 20,253 shares in the company, valued at $914,422.95. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Shares of Quidel Co. (QDEL) traded up $0.43 during midday trading on Friday, hitting $46.89. 333,693 shares of the company’s stock traded hands, compared to its average volume of 310,200. Quidel Co. has a 12 month low of $18.25 and a 12 month high of $47.60. The stock has a market capitalization of $1,526.80, a P/E ratio of -312.58, a PEG ratio of 1.45 and a beta of 1.15. The company has a quick ratio of 5.68, a current ratio of 6.28 and a debt-to-equity ratio of 0.70.

Quidel (NASDAQ:QDEL) last announced its quarterly earnings results on Wednesday, November 1st. The company reported ($0.16) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.05 by ($0.21). Quidel had a negative net margin of 2.33% and a negative return on equity of 2.36%. The business had revenue of $50.89 million during the quarter, compared to analysts’ expectations of $50.47 million. During the same period last year, the company earned $0.10 EPS. The firm’s revenue for the quarter was up 3.1% on a year-over-year basis. equities research analysts expect that Quidel Co. will post -0.23 earnings per share for the current fiscal year.

Several research analysts have weighed in on the stock. CL King upgraded shares of Quidel from a “neutral” rating to a “buy” rating and set a $52.00 target price on the stock in a research report on Thursday. Zacks Investment Research lowered shares of Quidel from a “hold” rating to a “strong sell” rating in a research report on Thursday, December 28th. Piper Jaffray Companies upgraded shares of Quidel from a “neutral” rating to an “overweight” rating and upped their target price for the stock from $35.00 to $50.00 in a research report on Tuesday, September 19th. Canaccord Genuity restated a “buy” rating and set a $48.00 target price (up from $42.00) on shares of Quidel in a research report on Tuesday, September 19th. Finally, BidaskClub upgraded shares of Quidel from a “hold” rating to a “buy” rating in a research report on Thursday, December 21st. One analyst has rated the stock with a sell rating and seven have given a buy rating to the stock. Quidel currently has a consensus rating of “Buy” and a consensus price target of $50.00.

Hedge funds and other institutional investors have recently made changes to their positions in the business. Acrospire Investment Management LLC lifted its holdings in shares of Quidel by 42.2% in the second quarter. Acrospire Investment Management LLC now owns 3,678 shares of the company’s stock valued at $100,000 after purchasing an additional 1,091 shares in the last quarter. Great West Life Assurance Co. Can lifted its holdings in shares of Quidel by 162.7% in the third quarter. Great West Life Assurance Co. Can now owns 4,642 shares of the company’s stock valued at $204,000 after purchasing an additional 2,875 shares in the last quarter. Jane Street Group LLC purchased a new stake in shares of Quidel in the third quarter valued at about $205,000. Legal & General Group Plc lifted its holdings in shares of Quidel by 4.0% in the second quarter. Legal & General Group Plc now owns 7,209 shares of the company’s stock valued at $197,000 after purchasing an additional 278 shares in the last quarter. Finally, Russell Investments Group Ltd. purchased a new stake in shares of Quidel in the second quarter valued at about $209,000. 92.67% of the stock is currently owned by institutional investors.

WARNING: “Quidel Co. (QDEL) SVP Ratan S. Borkar Sells 29,880 Shares” was first posted by American Banking News and is owned by of American Banking News. If you are viewing this article on another publication, it was illegally stolen and republished in violation of US and international copyright and trademark laws. The original version of this article can be viewed at https://www.americanbankingnews.com/2018/01/05/quidel-co-qdel-svp-ratan-s-borkar-sells-29880-shares.html.

Quidel Company Profile

Quidel Corporation is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions are separated into four product categories: immunoassays, molecular assays, virology and specialty products. The Company sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics, pharmacies and wellness screening centers.

Insider Buying and Selling by Quarter for Quidel (NASDAQ:QDEL)

Receive News & Ratings for Quidel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quidel and related companies with MarketBeat.com's FREE daily email newsletter.